InspireMD, Inc. Files 8-K for Material Definitive Agreement

Ticker: NSPR · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateOct 15, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.0001, $500,000, $22,911.75
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, 8-k

TL;DR

InspireMD signed a big deal, details TBD.

AI Summary

On October 9, 2024, InspireMD, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Miami, Florida, filed this 8-K report to disclose this significant event. The filing does not provide specific details on the agreement's nature or financial implications.

Why It Matters

This filing indicates a significant new contract or partnership for InspireMD, Inc., which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which is significant, but lacks specific details about the agreement's terms and potential impact, creating uncertainty.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by InspireMD, Inc. on October 9, 2024?

The filing does not specify the nature of the material definitive agreement.

What is InspireMD, Inc.'s principal business?

InspireMD, Inc. is in the business of Surgical & Medical Instruments & Apparatus, SIC code 3841.

Where are InspireMD, Inc.'s principal executive offices located?

InspireMD, Inc.'s principal executive offices are located at 6303 Waterford District Drive, Suite 215, Miami, Florida 33126.

When was InspireMD, Inc. incorporated?

InspireMD, Inc. was incorporated in Delaware.

What is the SEC file number for InspireMD, Inc.?

The SEC file number for InspireMD, Inc. is 001-35731.

Filing Stats: 893 words · 4 min read · ~3 pages · Grade level 10.8 · Accepted 2024-10-15 07:10:22

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: October 15, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing